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Na Rae Kim,1 Ju Hee Kang,2,3 Oh Woong Kwon,4 Seok Joon Lee,5 Jung Hyub Oh,1,3 and
Hee Seung Chin1
PURPOSE. This study was undertaken to investigate the associ-
ation between the complement factor H (CFH) gene and exu-
dative age-related macular degeneration (AMD) in Korean pa-
tients.
METHODS. Genomic DNA was isolated from the peripheral
leukocytes of patients with exudative AMD (n  114) and
control subjects (n  187). The sole criterion for exudative
AMD was the presence of choroidal neovascularization. Four
single-nucleotide polymorphisms (SNPs: 275CT, I62V,
Y402H, and IVS15) located in promoter, exon 2, exon 9, and
intron 15 of the CFH gene were genotyped by PCR-based direct
sequencing.
RESULTS. The frequency of the C allele of Y402H (AMD, 10.5%;
control, 6.5%) was found to be lower in Koreans than in
Caucasians. In the present study, the difference between the
frequencies of Y402H in cases and control subjects did not
reach statistical significance (P  0.071). However, the fre-
quencies of the major alleles of three SNPs (275CT, I62V,
and IVS15) were significantly different in patients and control
subjects, and these SNPs were found to be separately associ-
ated with an elevated risk of exudative AMD. Seven haplotypes
were identified in Koreans. Haplotype analysis showed that
two haplotypes (TGTG, CGTG) conferred significantly higher
risks of exudative AMD (P  0.013, 0.035), and one haplotype
(CATA) was significantly protective (P  0.001).
CONCLUSIONS. In Korean subjects, CFH polymorphism appears
to be a considerable hereditary contributor to exudative AMD.
Y402H polymorphism which has been suggested to be a major
risk factor of AMD in Caucasians was found to be only margin-
ally associated with exudative AMD with low frequency,
whereas three adjacent SNPs in the CFH gene were signifi-
cantly associated with AMD in Koreans. (Invest Ophthalmol
Vis Sci. 2008;49:2071–2076) DOI:10.1167/iovs.07-1195
Age-related macular degeneration (AMD) is the primarycause of severe vision loss in the elderly. It commonly
occurs in patients older than 50 years and usually affects both
eyes.1 AMD is a genetically complex disorder of the photore-
ceptor-retinal pigment epithelium (RPE)-Bruch’s membrane-
choriocapillaris complex. Early signs are characterized by the
presence of soft drusen, areas of increased pigment or hyper-
pigmentation (in the outer retina or choroid), and/or areas of
depigmentation or hypopigmentation of the RPE. Advanced
disease manifests either as geographic atrophy or choroidal
neovascularization.2
Several risk factors, including aging, cigarette smoking, and
arterial hypertension, have been proposed, but only a fraction
of exudative AMD cases can be attributed to these risk factors.3
The prevailing view is that AMD is a complex disorder derived
from interactions between multiple genetic and environmental
risk factors. Genetic influences on AMD have been well estab-
lished by family and twin studies.4 However, AMD appears to
be the product of interactions between multiple susceptible
loci rather than being due to a collection of single-gene disor-
ders.5
The Y402H polymorphism in complement factor H (CFH)
gene on chromosome 1, area q31, has been reported to be a
risk factor for AMD in North America and Europe.5–14 How-
ever, the majority of these previous studies enrolled predomi-
nantly Caucasians of European descent, and it is known that
genetic risks of AMD are dependent on ethnicity.15 Many
polymorphisms are potentially associated with AMD develop-
ment: Y402H is most likely to be associated with AMD in
Caucasians, whereas other SNPs have been reported to be
associated with AMD in other races, particularly in Asians.16–19
Furthermore, previous studies have suggested that haplotype
analysis rather than genotype analysis of the single Y402H SNP
is required to clarify the association between genetic factors
and AMD susceptibility.
In Asia, the prevalence of AMD is increasing rapidly due to
population aging. To the best of our knowledge, this is the first
study to investigate the association between genetic factors
and exudative AMD in Korean patients. Here, we evaluated the
relationships between four common polymorphisms in the
CFH gene—namely, 275CT, I62V, Y402H, and IVS15 (SNP
ID: rs3753394, rs800292, rs1061170, and rs1329428) and AMD
in Koreans.
METHODS
Subjects
This prospective case–control study was approved by the institutional
review board (IRB) of Inha University Hospital and was conducted in
accordance with the Declaration of Helsinki. Written informed consent
was obtained from all volunteers. Based on history-taking findings, all
study subjects resided in the same geographic area and had similar
lifestyles, in terms of likely exposure to sunlight, alcohol use, and
physical exercise.
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Three general hospitals participated (i.e., Inha University Hospital,
Severence Hospital, and Wonju Christian Hospital in Korea). All indi-
viduals were enrolled at these three centers by using the same proto-
col. Inclusion criteria were as follows: (1) age 50 years; (2) a diag-
nosed of exudative AMD after undergoing comprehensive ophthalmic
examinations, which included fundus fluorescein angiography; and (3)
the presence of a choroidal neovascular membrane in either or both
eyes for a diagnosis of exudative disease. Exclusion criteria included
the presence of geographic atrophy (GA) or a large drusen in the
absence of choroidal neovascularization. Secondary choroidal neovas-
cular diseases, such as, degenerative myopia, angioid streaks, idio-
pathic choroidal neovascularization, and presumed ocular histoplasmo-
sis syndrome, were excluded based on clinical presentations and
angiographic manifestations.
Unrelated control subjects were recruited from among patients
with no macular pathology or any other eye disease, except for mild
senile cataract, and were more than 50 years of age. In addition, the
control subjects had no known family history of AMD. Fundus photog-
raphy was performed routinely on all control subjects.
Genotyping
Peripheral venous blood was collected from all subjects into 5-mL
EDTA tubes. Genomic DNA was extracted from leukocytes by using
commercially available kits (QIAmpDNA; Qiagen, Valencia, CA), and
polymorphic sites were amplified by PCR with specific primers. PCR
products were used as the templates for direct DNA sequencing (Big
Dye Terminator cycle sequencing kits; Applied Biosystems, Inc. [ABI],
Foster City, CA) on an automated sequencer (model 3730; ABI).
Statistics
Allele and genotype frequencies were estimated by using the allele-
counting method. Hardy-Weinberg estimates for genotypes and esti-
mated haplotype frequencies were calculated with the HapAnalyzer
(ver. 1.0; a minimum haplotype analysis system for association studies
provided in the public domain by the National Genome Research
Institute, Seoul, Korea; http://hap.ngri.go.kr/right.html).
Numerical data were analyzed with Student’s t-test. Associations
between several known risk factors and AMD were examined using
separate logistic regression models. These known risk factors were
treated as categorical variables: age (50–59 years, 0; 60–69 years, 1;
and 70 years, 2), gender (male, 0; female, 1), smoking status (non-
smoking, 0; 20 pack-years, 1; 20 pack-years, 2), and hypercholes-
terolemia (200, 0;  200, 1).
The allele and genotype frequencies of cases and control subjects
were compared by 2 analysis. 2 analysis was used to calculate the
unadjusted odds ratios of alleles and genotypes. Conditional logistic
regression analysis models were considered for each locus separately,
to estimate odds ratios and their corresponding 95% confidence inter-
vals (CIs), after adjusting for other risk factors. All genotypes were set
as categorical variables (homozygotes for the risk allele, 2; heterozy-
gotes, 1; no risk allele, 0).
Pair-wise linkage disequilibrium (LD; D) estimations between SNPs
at the CFH locus and EM-based haplotype association analysis were
performed using the HapAnalyzer software. All haplotypes with a
frequency of 1% were selected. ORs for the cases and control sub-
jects were calculated, and 95% CIs were calculated. Homozygotes and
heterozygotes for these haplotypes among cases and control subjects
were compared by 2 test.
Statistical analysis was performed with commercial software (SPSS
for Windows, ver. 12.0; SPSS Inc., Chicago, IL). The criterion for
statistical significance was P  0.05.
RESULTS
Participants
In total, 114 patients with exudative AMD and 187 control
subjects participated in the study. The baseline characteristics
of patients and control subjects are shown in Table 1. The
TABLE 1. Baseline Characteristics of the Study Subjects*
Cases
(n  114)
Controls
(n  187)
All Subjects
(n  301) P
Ages (y)† 68.25  8.806 66.83  7.794 67.37  8.207 P  0.148
Sex, n (%)
Male 47 (41.2) 94 (50.3) 141 (46.8) P  0.127
Female 67 (58.8) 93 (49.7) 160 (53.2)
* Cases and controls were matched for age and sex.
† Mean  SD.
TABLE 2. Description of Variables
Cases
(n  114)
Controls
(n  187) P* P
Odds Ratio
(95% CI)†
Age (y)
50–59 15 (13.2) 33 (17.6) 1.000 (reference)
60–69 48 (42.1) 99 (52.9) 0.857 1.067 (0.529–2.150)
70 51 (44.7) 55 (29.4) 0.027 0.052 2.040 (0.993–4.189)
Sex
Male 47 (41.2) 94 (50.3) 1.000 (reference)
Female 67 (58.8) 93 (49.7) 0.128 0.128 1.441 (0.900–2.306)
Hypertension‡
No 39 (34.2) 79 (43.2) 1.000 (reference)
Yes 75 (65.8) 104 (56.8) 0.126 0.126 1.461 (0.899–2.373)
Cholesterol (mg/dL)
200 33 (28.9) 71 (38.0) 1.000 (reference)
200 81 (71.1) 116 (62.0) 0.111 0.111 1.502 (0.910–2.480)
Cigarette smoking§
Never 60 (52.6) 128 (68.4) 1.000 (reference)
20 24 (21.1) 30 (16.0) 0.090 1.707 (0.920–3.167)
20 30 (26.3) 29 (15.5) 0.019 0.009 2.207 (1.217–4.003)
* 2 test for frequency.
† ORs and 95% CIs were determined by logistic regression analysis.
‡ Sample sizes sum to slightly less than the total number of cases and controls because a small amount
of covariate data were unavailable.
§ Pack years.
2072 Kim et al. IOVS, May 2008, Vol. 49, No. 5
mean ages (P  0.148) and gender distributions (P  0.127) of
the patients and control subjects were not significantly differ-
ent.
Of the putative risk factors, aging (P  0.027) and cigarette
smoking (P  0.019) were found to be significantly associated
with AMD, whereas no significant association was found for
sex (P  0.128), hypercholesterolemia (P  0.111), or hyper-
tension (P  0.126). Hypercholesterolemia and hypertension
tended to be more prevalent in patients than in control sub-
jects (Table 2).
Association between the Four SNPs and AMD
The genotype frequency distributions of patients and control
subjects were in Hardy-Weinberg equilibrium. As shown in
Table 3, the frequency of the Y402H C allele, which has been
suggested to be a major risk allele of AMD in North America,
was relatively low in patients and control subjects. The differ-
ent Y402H frequencies of cases and control subjects did not
reach statistical significance (P  0.071; 10.5% in exudative
AMD cases, and 6.5% in control subjects). Moreover, the
Y402H C allele was not significantly associated with AMD but
tended to be associated with susceptibility to AMD (OR: 1.716;
95% CI: 0.950–3.100). The allele frequencies of the other three
SNPs flanking Y402H were significantly different in cases and
control subjects. The major alleles of the three SNPs (T for
275CT, G for I62V, and G for IVS15) conferred 1.576-fold
(95% CI: 1.131–2.195, P  0.007), 2.205-fold (95% CI: 1.553–
3.132, P  0.001), and 1.997-fold (95% CI: 1.426–2.797, P 
0.001) increases in the likelihood of exudative AMD, respec-
tively. After adjusting for known risk factors, significant asso-
ciations were found for 275CT, I62V, and IVS15, but not
for Y402H (Table 3).
Genotype analysis showed no significant difference be-
tween the frequencies of Y402H genotypes in patients (TT,
79.8%; TC, 19.3%; CC, 0.9%) and control subjects (TT, 87.7%;
TC, 11.8%; CC, 0.5%; P  0.183). However, the genotype
distributions of the other three SNPs were found to be signif-
icantly different in cases and control subjects (275CT,
I62V, and IVS15; P  0.008,  0.001, and  0.001, respec-
tively). Individuals homozygous with two risk alleles at
275CT, I62V, and IVS15 were more likely to have AMD
than those with no risk allele (OR: 2.295, 95% CI: 1.219–4.324;
OR: 4.091, 95% CI: 1.963–8.526; OR: 3.430, 95% CI: 1.773–
2.582), but individuals homozygous for C alleles at Y402H
showed no significant increase in risk (OR: 1.802, 95% CI:
0.111–29.155). Individuals with one risk allele (heterozygous)
of the four SNPs did not show a significant increase in risk
versus individuals with no risk allele. After adjustment for other
risk factors, similar trends were observed (Table 3).
Linkage Disequilibrium and Associations between
Haplotypes and AMD
The poor association between the Y402H variant and AMD was
further confirmed by an analysis of pair-wise LD among these
SNPs in our cohort (Table 4, Fig. 1). Haplotype analysis based
on the four SNPs predicted nine different haplotypes. Of these,
seven haplotypes with a frequency of 1% were selected.
Haplotype estimations in patients with exudative AMD and
control subjects identified two haplotypes as risk factors and
one as a protective factor. Specifically, two haplotypes, K1
(TGTG) and K7 (CGTG), were significantly associated with
exudative AMD. These results are consistent with our SNP
analysis results, shown in Table 3. The most frequent at-risk
haplotype, K1 (TGTG), contained the major alleles of
275CT, I62V, and IVS15, and occurred in 46.9% of patients
and in 36.6% of control subjects. K1 was found to confer a
1.53-fold (95% CI: 1.095–2.137, P  0.013) increased likeli- TA
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hood of exudative AMD. Another minor but significant risk
haplotype, K7 (CGTG) conferred a 3.917-fold (95% CI: 1.003–
15.303, P  0.035) increased likelihood of exudative AMD.
Homozygotes for K1 accounted for 23.7% of cases and 11.8% of
control subjects (OR: 2.328, 95% CI: 1.252–4.327, P  0.006),
whereas no individual was found to be homozygous for K7.
The protective haplotype K2 (CATA) was found in 44.7% of
control subjects and 26.3% of patients (OR: 0.443, 95% CI:
0.309–0.634, P  0.001) and homozygotes for this haplotype
were present at frequencies of 21.9% and 9.6% in control
subjects and AMD cases, respectively (OR: 0.380, 95% CI:
0.187–0.775, P  0.004).
Individuals heterozygous for one risk haplotype and an-
other protective haplotype (K1/K2) showed a significantly
lower risk of exudative AMD (OR: 0.506, 95% CI: 0.290–0.884,
P  0.010). The protective haplotype K2 canceled out the
effect of risk haplotype K1. Heterozygotes for two different
risk haplotype (K1/K7) were found to have a 9.394-fold (95%
CI: 1.082–81.524, P  0.023) increased likelihood having of
exudative AMD (Table 4).
LD analysis showed extensive LD across an extended region
of CFH. Three SNPs (I62V, Y402H, and IVS15) were virtually in
complete LD, as were Y402H and IVS15 at exon 9 and intron
15, respectively (D  1). As is evident in Figure 1, pair-wise LD
analysis showed I62V in high LD with Y402H (D  1) and
IVS15 (D  0.896).
DISCUSSION
CFH Gene Associations in Koreans
Inflammation has been suggested to play a role in the patho-
genesis of AMD, and of the molecules involved in the comple-
ment system, CFH (complement factor H) protein is known as
a critical regulator of the complement alternative pathway
activation.20 In the present study, we focused on the associa-
tions between the common four polymorphisms in CFH and
AMD. Our results suggest that the CFH polymorphisms are
associated with exudative AMD in Koreans. The Y402H variant
showed a marginal association with AMD (P  0.071). How-
ever, the major alleles of the three other SNPs examined
(275CT, I62V, IVS15) were found to increase the risk of
exudative AMD significantly. The common haplotype K1,
which possesses these SNPs (TGTG; with an estimated haplo-
type frequency of 46.9%), was found to be significantly asso-
ciated with susceptibility to exudative AMD (OR: 1.530, 95%
CI: 1.095–2.137). Moreover, homozygotes for this haplotype
(K1/K1) were found to be at significant risk (OR: 2.328, 95%
CI: 1.252–4.327).
275CT is located in the CFH promoter region, which
regulates CFH transcription (e.g., nuclear factor [NF]-B re-
FIGURE 1. LD patterns for 275CT, I62V, Y402H, and IVS15 in
CFH. A set of the four informative SNPs in the CFH gene were analyzed
for pair-wise LD. R2 and D values are shown. Gray or black squares:
significant LD between SNP pairs (HapAnalyzer ver. 1.0).
TABLE 4. CFH Haplotypes: Association Analysis
275C>T I62V Y402H IVS15 Odds Ratio (95% CI) P
Frequency
Cases
(n  114)
Controls
(n  187)
Haplotypes*
K1† T G T G 1.530 (1.095–2.137) 0.013 107 (46.9) 137 (36.6)
K2‡ C A T A 0.443 (0.309–0.634) 0.001 60 (26.3) 167 (44.7)
K3 C G C G 1.636 (0.900–2.973) 0.103 23 (10.1) 24 (6.4)
K4 T G T A 1.147 (0.614–2.143) 0.666 18 (7.8) 26 (6.95)
K5 C G T A 1.417 (0.470–4.270) 0.534 6 (2.63) 7 (1.87)
K6 C A T G 1.716 (0.369–3.749) 0.784 5 (2.19) 7 (1.87)
K7† C G T G 3.917 (1.003–15.303) 0.035 7 (3.1) 3 (0.8)
Diplotypes (homozygous status)
K1/K1† T G T G/T G T G 2.328 (1.252–4.327) 0.006 27 (23.7) 22 (11.8)
K2/K2‡ C A T A/C A T A 0.380 (0.187–0.775) 0.004 11 (9.6) 41 (21.9)
K7/K7 C G T G/C G T G N/A N/A 0 (0) 0 (0)
Diplotypes (heterozygous status)
K1/K2‡ T G T G/C A T A 0.506 (0.290–0.884) 0.010 22 (19.3) 60 (32.1)
K1/K7† T G T G/C G T G 9.394 (1.082–81.524) 0.023 5 (4.4) 1 (0.5)
K2/K7 C A T A/C G T G 0.823 (0.074–9.180) 0.681 1 (0.9) 2 (1.1)
* All haplotypes with a frequency of 1% are displayed.
† Risk haplotypes.
‡ Protective haplotypes.
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sponsive element).21–22 Therefore, it is possible that the func-
tion of this promoter is impaired by the presence of the T allele
and that this leads to relatively lower factor H plasma levels.18
The exon2 I62V variant is located in SCR2, which contains a
regulatory domain for cofactor- and decay-accelerating activity
and a binding site for C3b.5,23 Furthermore, I62V is located in
a predicted exon splice enhancer, and thus this polymorphism
could cause splicing errors and alter CFH function and AMD
development.24
The Y402H Polymorphism and AMD Risk
Several studies in Caucasian populations have shown that
Y402H SNP is significantly associated with AMD and that fre-
quencies of the C allele range from 55% to 94% in AMD and
from 34% to 46% in control subjects.5–14 In the present study,
the frequency of the Y402H C allele was found to be lower in
Koreans (10.5% in patients, 6.5% in control subjects) than in
Caucasians, but to show minimal difference between patients
and control subjects (P  0.071) and not to increase signifi-
cantly the risk of exudative AMD (OR: 1.716, 95% CI: 0.950–
3.100). Our results suggest that CFH polymorphisms are re-
lated to exudative AMD in Koreans, but that the influence of
Y402H SNP is only marginal.
The exon 9 Y402H variant lies within the SCR7 domain of
CFH, which binds heparin and C-reactive protein. In previous
studies, a high-level association between this variant and the
risk of AMD (by single SNP analyses) has focused attention on
this variant. This attention is sustained despite observation of a
stronger association between the disease and other nearby
noncoding SNPs.25 A recent composite likelihood analysis of
the association between AMD and the CFH gene suggested that
the locus at the 5 end of the CFH gene is also likely to be an
important source of sequence variations.26
Although the Y402H variant plays a major role in the etiol-
ogy of AMD, it is unlikely to be the only major determinant of
disease susceptibility. It may be that the CFH Y402H polymor-
phism is a susceptibility locus for the formation of soft drusen,
but fewer than 30% of Caucasians that present with soft drusen
eventually progress to an advanced form of AMD; thus, it
appears that other variants are responsible for progression to
advanced disease.27 This argument is supported by the obser-
vation that more than half of Caucasians possess at least one
copy of the C allele, but most do not develop AMD, and thus,
other factors, both genetic and environmental, are likely to
determine risk.12 Moreover, most Korean patients do not have
Y402H, and thus, other as yet unidentified genetic variants also
probably promote disease progression.
Ethnicity and CFH Polymorphisms
The frequencies of CFH polymorphisms are obviously different
in Caucasians and Asians. In the present study, we compared
haplotype frequencies of two SNPs (I62V, Y402H) in Cauca-
sians, Japanese, Chinese, and Koreans using the findings of the
present and previous studies (Table 5).5,16,19 It was found that
the haplotype frequencies in our patients with AMD show the
similarity to that in Japanese and Chinese. In Asian, haplotype
H1 (GT) was more frequent in patients with AMD and haplo-
type H2 (AT) in control subjects, whereas haplotype H3 (GC)
is most common in Caucasians.
In terms of Y402H variant, Grassi et al.15 reported consid-
erable ethnic variations and also suggested that other uniden-
tified genetic factors evidently importantly contribute to the
pathogenesis of AMD. The frequency of Y402H in Asians as
determined by the International HapMap Project is much
lower than in Caucasians (i.e., 8.1% in Japanese and 6.8% in
Chinese versus more than 35% in Caucasians).15 In the present
study, the frequency of the risk allele C was found to be 7.97%.
Moreover, in agreement with our results, previous studies
conducted in Japanese and Chinese populations concluded
that the Y402H variant is not definitively associated with exu-
dative AMD.16–19
The only SNP reported in the CFH promoter275CT was
found to be unrelated to AMD in Caucasians.5,8 However, this
association has been reported in China,19 and we also detected
a significant association in our study population. On the other
hand, I62V has been reported to be associated with AMD in
Caucasians,5–6 Chinese,19 and Japanese.17 Furthermore, Cau-
casians6 and Chinese19 homozygous for the C allele of IVS15
have been reported to have a higher risk of developing AMD.
It has been well established that the prevalence of AMD
varies substantially between races.28,29 The prevalence of ad-
vanced AMD in Japanese is much lower than in Caucasians,29
and it has been suggested that this lower prevalence may be a
consequence of the low frequency of Y402H variant in
Asians.11 Moreover, the phenotypic spectrum of AMD among
these different populations is also heterogeneous. For exam-
ple, soft drusen, an inflammatory deposit containing CFH pro-
tein is less frequently observed in the Japanese,29–31 and stan-
dard photodynamic therapy for wet AMD in Japanese patients
is associated with greater angiographic and vision benefits than
in Caucasians.31 However, no accurate epidemiologic study
has been conducted in the Korean population, although it is
generally assumed that disease phenotypes and treatment re-
sponse are similar to those observed in the Japanese. We
suspect that the low frequency of the C allele in Koreans is a
reason for the low prevalence of AMD, rare features of uncon-
trolled soft drusen accumulation, and a better response, and
suggest that more detailed genotype–phenotype correlation
studies be conducted in Asian populations.
Potential Weaknesses
The main study limitation is its low sample size. To distinguish
statistically the Y402H frequency in cases and control subjects,
182 patients and 182 control subjects should have been re-
cruited, which would have provided sufficient statistical
power to detect differences of 4% (  0.05, statistical
TABLE 5. CFH Haplotype Comparisons of rs800292 (I62V) and rs1061170 (Y402H) in Koreans,
Chinese, Japanese, and Caucasians
Koreans Chinese* Japanese† Caucasians‡
Cases Controls Cases Controls Cases Controls Cases Controls
H1 (GT) 0.605 0.463 0.69 0.58 0.62 0.57 N/A N/A
H2 (AT) 0.289 0.473 0.25 0.38 0.30 0.40 0.12 0.21
H3 (GC) 0.105 0.064 0.058 0.039 0.08 0.03 0.50 0.29
* Chinese: Chen et al.19
† Japanese: Gotoh et al.16
‡ Caucasians: Hageman et al.5
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power  0.8). Thus, the present study is limited in terms of
detecting significant differences. However, it was difficult to
calculate appropriate sample sizes based on limited knowledge
of the proportion of individuals who carry the risk allele
(Y402H) in the Korean population. More comprehensive anal-
ysis of variations at this locus is necessary in a larger popula-
tion.
CONCLUSION
In our Korean cohort, haplotype analysis indicated that the
CFH gene meaningfully contributes to exudative AMD. More-
over, the Y402H variant was found to be much less frequent in
our Korean cohort than has been observed in Caucasians,
nevertheless, it was found to be marginally associated with
AMD. Further studies in different ethnic populations widen our
understanding of the role of the CFH polymorphisms with
respect to susceptibility to AMD. It is hoped that, in the future,
at-risk populations can be identified decades before likely clin-
ical AMD manifestation, as this would allow the individual to
make lifestyle and nutritional modifications, and facilitate the
initiation of yet to be discovered therapies.
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